cyclopentane has been researched along with cyclin d1 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hsiang, CH; Straus, DS | 1 |
| Lavigne, C; Thierry, AR | 1 |
| Cai, JB; Dong, JH; Jiang, GS; Liu, Y; Tang, ST; Tong, QS; Zeng, FQ; Zheng, LD | 1 |
| Cai, JB; Hu, B; Jiang, GS; Liu, Y; Tong, QS; Zeng, FQ; Zheng, LD | 1 |
| Chong, Y; Han, Y; Liu, H; Liu, X; Niu, M | 1 |
| Ben-David, Y; Ju, Y; Rotin, D; Zacksenhaus, E | 1 |
6 other study(ies) available for cyclopentane and cyclin d1
| Article | Year |
|---|---|
Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Topics: Animals; Base Sequence; Binding Sites; Blotting, Western; Breast Neoplasms; Cell Cycle; Cyclin D1; Cyclopentanes; Electrophoretic Mobility Shift Assay; Flow Cytometry; G1 Phase; Gene Expression Regulation, Neoplastic; Genes, bcl-1; Humans; Molecular Sequence Data; Promoter Regions, Genetic; Protein Binding; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; S Phase; Sequence Deletion; Sequence Homology, Nucleic Acid; Transcription Initiation Site; Tumor Cells, Cultured | 2002 |
Specific subcellular localization of siRNAs delivered by lipoplex in MCF-7 breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cyclin D1; Cyclopentanes; Estradiol; Humans; Immunohistochemistry; Intracellular Space; Liposomes; Membrane Proteins; Microscopy, Fluorescence; RNA, Small Interfering; Transfection; Vesicular Transport Proteins | 2007 |
Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines.
Topics: Acetates; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclopentanes; Down-Regulation; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Neuroblastoma; Oxylipins; Plant Growth Regulators; Proliferating Cell Nuclear Antigen; Survivin; X-Linked Inhibitor of Apoptosis Protein | 2008 |
[Methyl jasmonate induces apoptosis of human neuroblastoma cell line BE(2) -C and its mechanism].
Topics: Acetates; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclopentanes; Dose-Response Relationship, Drug; Down-Regulation; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neuroblastoma; Oxylipins; RNA, Messenger; S Phase; Survivin; X-Linked Inhibitor of Apoptosis Protein | 2008 |
Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer.
Topics: Aminopyridines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin B; Cyclin D1; Cyclopentanes; Exportin 1 Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Karyopherins; Ovarian Neoplasms; Receptors, Cytoplasmic and Nuclear | 2015 |
Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Cell Cycle Proteins; Cell Line, Tumor; Cyclin D1; Cyclopentanes; Drug Synergism; Elongation Factor 2 Kinase; Female; Gene Silencing; Glutaminase; Humans; Protein Kinase Inhibitors; Proteins; Proto-Oncogene Proteins c-myc; Sulfides; Thiadiazoles; Triple Negative Breast Neoplasms | 2021 |